Enwei Pharmaceutical Co

Enwei Pharmaceutical Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Enwei Pharmaceutical Co (301331.SZ) as of Nov 1, 2026 is 15.31. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 34.84 — a change of -56.07% (lower).

EV/FCF

15.31

YoY

-56.07%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Enwei Pharmaceutical Co is 2025 15.31 . EV/FCF (Enterprise Value to Free Cash Flow) of Enwei Pharmaceutical Co was 2024 34.84 . It decreases by -56.07% lower compared to the previous year.

The Enwei Pharmaceutical Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
8.27 CNY
Jan 1, 2020
17.20 CNY
Jan 1, 2021
16.50 CNY
Jan 1, 2022
21.00 CNY
Jan 1, 2023
-16.28 CNY
Jan 1, 2024
34.84 CNY
Jan 1, 2025
15.31 CNY
The Enwei Pharmaceutical Co EV/FCF history
YEAREV/FCFYoY
15.31-56.07%
34.84-314.04%
-16.28-177.53%
21.00+27.24%
16.50-4.06%
17.20+107.92%
8.27—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enwei Pharmaceutical Co Stock analysis

What does Enwei Pharmaceutical Co do? Enwei Pharmaceutical Co., Ltd. generates revenue through the research, development, production, and sales of proprietary Chinese and chemical medicines. The company's main products include Jieeryin lotion, Jieeryin ointment, Jieeryin effervescent tablets, Shanmai Jianpi oral liquid, Qingjing capsules, and Danxiong Tongmai granules, which are primarily sold via direct sales and e-commerce channels. Its focus on gynecological products, pediatric medicines, and respiratory medicines targets domestic consumers seeking specialized healthcare solutions. The firm's domestic market strategy emphasizes direct customer engagement and online sales to reach its target segments. The company's product portfolio is tailored to specific health needs, with Jieeryin products addressing gynecological concerns, Shanmai Jianpi oral liquid supporting digestive health, Qingjing capsules for gynecological treatments, and Danxiong Tongmai granules targeting cardiovascular health. These offerings are distributed through direct sales teams and e-commerce platforms, aligning with the domestic market's preference for accessible healthcare products. Enwei's domestic focus ensures that its products meet local regulatory standards and consumer demands. Enwei Pharmaceutical's revenue streams are driven by the consistent demand for its specialized medicine categories, particularly in gynecology, pediatrics, and respiratory care. The firm's domestic market presence allows it to build strong relationships with healthcare providers and end-users, facilitating repeat purchases and brand loyalty. By concentrating on these key therapeutic areas, Enwei effectively serves its core customer segments without expanding into international markets. Enwei Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enwei Pharmaceutical Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Enwei Pharmaceutical Co is 15.31 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Enwei Pharmaceutical Co changed from 34.84 to 15.31, representing a -56.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Enwei Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Enwei Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enwei Pharmaceutical Co

All Key Metrics — Enwei Pharmaceutical Co